BPC-157 + TB-500
The two most-studied tissue-repair research peptides co-formulated in a single 20 mg vial.
01At a Glance
| Compound | BPC-157 + TB-500 |
| Classification | Regenerative research compound |
| Constituents | BPC-157 10 mg — 1,419.5 g/mol TB-500 10 mg — 4,963.4 g/mol |
| Molecular weight | Blend — see constituents |
| Sequence / Form | BPC-157 10 mg · TB-500 10 mg |
| Purity | ≥98% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
02Mechanism of Action
This blend pairs the two compounds most frequently used together in tissue-repair research. BPC-157, a pentadecapeptide derived from a gastric protein sequence, is studied for VEGF-pathway signaling, fibroblast migration and angiogenesis in injury models.
TB-500 is the synthetic fragment corresponding to the actin-binding domain of thymosin β4, investigated for actin sequestration and its effects on cell motility and migration.
The two act on distinct mechanisms — one predominantly on growth-factor signaling, the other on cytoskeletal dynamics — which is the stated basis for studying them in combination. The combination itself is not separately characterised in published literature.
Research framing only · No human-use claims
03Research Context
- Paired-compound tissue-repair assays
- Angiogenesis and fibroblast-migration models
- Actin-dynamics research
- Tendon, ligament and soft-tissue repair models
04Quality & Verification
Ethos Bio presents compound information with an emphasis on identity verification, purity analysis, certificate access, and storage guidance. Product-specific documentation is available through the certificate page where applicable. Cold-chain shipping is available where required, and inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
05FAQ
What is in this blend?
A single lyophilized vial containing BPC-157 10 mg and TB-500 10 mg — 20 mg total peptide content, verified per constituent.
Why are BPC-157 and TB-500 studied together?
They act by different mechanisms — BPC-157 on growth-factor and angiogenic signaling, TB-500 on actin sequestration and cell motility. Combining them is common in repair-model research for that reason.
Can I buy them separately?
Yes. Both BPC-157 and TB-500 are available individually. The blend exists for single-reconstitution convenience in combined assays.
How should BPC-157 + TB-500 be stored?
BPC-157 + TB-500 ships lyophilized and should be handled per standard research-peptide practice — kept cold, protected from light and moisture, and reconstituted only for laboratory use. Cold-chain handling is used where required. For research use only.
Is BPC-157 + TB-500 approved for human use?
No. BPC-157 + TB-500 is sold strictly for laboratory research use only and is not a drug or supplement. It is not approved for human or veterinary use or consumption.
How is BPC-157 + TB-500 tested at Ethos Bio?
Every lot is independently verified by Kovera Labs on a third-party analytical panel — RP-HPLC purity and HPLC-MS identity confirmation — and a lot-specific certificate of analysis issued to Ethos Bio ships with the vial. See How We Test for the full methodology.